Listed

NextCure, Inc.

NXTCNasdaqCIK 1661059HealthcareFiscal year ends Dec 31

Reports and events: 119 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NextCure, Inc., Reports and events
FiledFormWhat it isAccession number
2024-03-0816:34 ETSC 13D/AOwnership report, active investor, amended0000947871-24-000274
2023-12-1407:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-23-019766
2023-11-0216:20 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-017429
2023-11-0216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-017418
2023-08-0316:26 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-013250
2023-08-0316:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-013237
2023-07-1916:05 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-082344
2023-06-2606:07 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-23-074450
2023-05-0416:30 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-008131
2023-05-0416:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-008118
2023-04-2816:09 ETDEF 14AProxy statementPeriod 2023-06-220001104659-23-052945
2023-03-0216:41 ET10-KAnnual reportPeriod 2022-12-310001558370-23-002698
2023-03-0216:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-23-002694
2022-11-0316:31 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016275
2022-11-0316:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-016263
2022-08-0416:27 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-012232
2022-08-0416:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-086121
2022-06-2317:01 ET8-K5.07 Shareholder vote results0001104659-22-073939
2022-05-0516:51 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-007439
2022-05-0516:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-056484
2022-04-2916:06 ETDEF 14AProxy statementPeriod 2022-06-230001104659-22-053530
2022-03-0317:01 ET10-KAnnual reportPeriod 2021-12-310001558370-22-002824
2022-03-0316:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-030025
2021-11-1516:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-139169
2021-11-0416:41 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-014632
2021-11-0416:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-134399
2021-10-0416:06 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-122499
2021-09-2416:10 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-119299
2021-08-0516:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-100794
2021-08-0516:29 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-010578
2021-06-2516:05 ET8-K5.07 Shareholder vote results0001104659-21-085703
2021-05-0617:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-062513
2021-05-0616:39 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-006266
2021-04-2916:19 ETDEF 14AProxy statementPeriod 2021-06-240001104659-21-057620
2021-04-2617:11 ET10-K/AAnnual report, amendedPeriod 2020-12-310001104659-21-054980
2021-03-0416:34 ET10-KAnnual reportPeriod 2020-12-310001558370-21-002384
2021-03-0416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-032110
2021-02-2417:14 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-027570
2021-01-1416:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-004252
2020-11-0516:18 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-012866
2020-09-1416:44 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-104856
2020-08-0616:14 ET10-QQuarterly reportPeriod 2020-06-300001558370-20-009660
2020-07-3116:19 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-089093
2020-07-1716:51 ET8-K5.02 Departure or appointment of officers or directors0001104659-20-084546
2020-07-1316:28 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-083106
2020-06-1116:08 ET8-K5.07 Shareholder vote results0001104659-20-072403
2020-05-0717:30 ET10-QQuarterly reportPeriod 2020-03-310001558370-20-005800
2020-04-2706:02 ETDEF 14AProxy statementPeriod 2020-06-110001047469-20-002583
2020-04-1418:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001123292-20-000663
2020-03-3007:12 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-039889

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:17 ET. Listed shows no prices and gives no investment advice.